The rat Pig-a mutation assay in single and 28 day-repeated dose study of cyclophosphamide: The PIGRET assay can detect the in vivo mutagenicity earlier than the RBC Pig-a assay

Genes and Environment

Volumn 36, Issue 4, 2014, Pages 191-198

  Kimoto, Takafumi ^a   Chikura, Satsuki ^a   Suzuki Okada, Kumiko ^a   Kobayashi, Xiaomei ^a   Itano, Yasuhiro ^a   Miura, Daishiro ^a   Kasahara, Yoshinori ^a  

^a TEIJIN LTD   (Japan)

Author keywords

Flow cytometry; In vivo mutation assay; Peripheral blood; Pig a gene

Indexed keywords

CYCLOPHOSPHAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINEAGE; CELL MUTANT; CONTROLLED STUDY; ERYTHROCYTE; GENETIC TOXICOLOGY; IN VIVO STUDY; KINETICS; MALE; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; RAT; RAT PIG A MUTATION ASSAY; RETICULOCYTE;

RATTUS; SUIDAE;

EID: 84918795580     PISSN: 18807046     EISSN: 18807062     Source Type: Journal    
DOI: 10.3123/jemsge.2014.025     Document Type: Article

References (18)

1. Dobrovolsky VN, Miura D, Heflich RH, Dertinger SD. The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Environ Mol Mutagen. 2010; 51: 825-35.
2. Bryce SM, Bemis JC, Dertinger SD. In vivo mutation assay based on the endogenous Pig-a locus. Environ Mol Mutagen. 2008; 49: 256-64.
3. Miura D, Dobrovolsky VN, Kasahara Y, Katsuura Y, Heflich RH. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ Mol Mutagen. 2008; 49: 614-21.
4. Miura D, Dobrovolsky VN, Mittelstaedt RA, Kasahara Y, Katsuura Y, Heflich RH. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ Mol Mutagen. 2008; 49: 622-30.
5. Schuler M, Gollapudi BB, Thybaud V, Kim JH. Need and potential value of the Pig-a in vivo mutation assay - A HESI perspective, Environ Mol Mutagen. 2011; 52: 685-9.
6. Dertinger SD, Phonethepswath S, Avlasevich S, Torous DK, Mereness J, Bryce SM, et al. Efficient monitoring of in vivo Pig-a gene mutation and chromosomal damage: Summary of 7 published studies and results from 11 new reference compounds, Toxicol Sci. 2012; 130: 328-48.
7. Dobrovolsky VN, Boctor SY, Twaddle NC, Doerge DR, Bishop ME, Manjanatha MG, et al. Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-specific antibody: application of the method for evaluating the in vivo genotoxicity of methylpheni-date in adolescent rats, Environ Mol Mutagen. 2010; 51: 138-45.
8. Kawagoe K, Takeda J, Endo Y, Kinoshita T. Molecular cloning of murine Pig-a, a gene for GPI-anchor biosynthesis, and demonstration of interspecies conservation of its structure, function, and genetic locus. Genomics. 1994; 23: 566-74.
9. Keller P, Payne JL, Tremml G, Greer PA, Gaboli M, Pandolfi PP, et al. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. J Exp Med. 2001; 194: 581-9.
10. Phonethepswath S, Bryce SM, Bemis JC, Dertinger SD. Erythrocyte-based Pig-a gene mutation assay: demonstration of cross-species potential. Mutat Res. 2008; 657: 122-6.
11. Miura D, Shaddock, JG, Mittelstaedt, RA, Dobrovolsky, VN, Kimoto, T, Kasahara Y, et al. Analysis of mutations in the Pig-a gene of spleen T-cells from N-ethyl-N-nitrosourea-treated Fisher 344 rats. Environ Mol Mutagen. 2011; 52: 419-23.
12. Miura D, Dobrovolsky VN, Kimoto T, Kasahara Y, Heflich RH. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat Res. 2009; 677: 86-92.
13. Dertinger SD, Phonethepswath S, Franklin D, Weller P, Torous DK, Bryce SM, et al. Integration of mutation and chromosomal damage endpoints into 28-day repeated dose toxicology studies. Toxicol Sci. 2010; 115: 401-11.
14. Kimoto T, Horibata K, Chikura S, Hashimoto K, Itoh S, Sanada H, et al. Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody. Mutat Res. 2013; 755: 126-34.
15. Cyclophosphamide for Injection, USP/Cyclophosphamide Tablets, USP. Document of Food and Drug Administration. Revised April 2012. http://www.accessdata. fda.gov/drugsatfdadocs/label/2012/012141s089lbl.pdf
16. Bhalli JA, Shaddock JG, Pearce MG, Dobrovolsky VN. Sensitivity of the Pig-a assay for detecting gene mutation in rats exposed acutely to strong clastogens. Mutagenesis. 2013; 28: 447-55.
17. Walker DM, Seilkop SK, Scott BR, Walker VE. Hprt mutant frequencies in splenic T-cells of male F344 rats exposed by inhalation to propylene. Environ Mol Mutagen. 2004; 43: 265-72.
18. Kimoto T, Chikura S, Suzuki K, Kobayashi XM, Itano Y, Miura D, et al. Effective use of the Pig-a gene mutation assay for mutagenicity screening: measuring CD59-deficient red blood cells in rats treated with genotoxic chemicals. J Toxicol Sci. 2012; 37: 943-55.